This article was originally published by Targeted Oncology As part of a virtual Case Based Peer Perspective event, Jesus G. Berdeja, MC, director of...
Research
MRD, Biomarkers in Multiple Myeloma
This article was originally published by AJMC MRD Should Be More Widely Used in Clinical Care of MM, Report Argues Advances in scientists'...
Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma
This article was originally published by Cancer Health New drugs to treat multiple myeloma are producing better results for patients, with fewer...
Exploring Challenges With CAR T Cells and NK Cells in Multiple Myeloma
This article was originally published by Targeted Oncology. C. Ola Landgren, MD, PhD, chief of Myeloma Service and hematologic oncologist at...
GSK nabs FDA approval for first-in-class multiple myeloma drug
Blenrep, an antibody-drug conjugate, is the first drug approved for multiple myeloma that targets the antigen BCMA. Several other companies are also...
Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma
For many patients with multiple myeloma, a new generation of drugs and drug combinations is producing better outcomes and fewer side effects. In...
“Good-Risk” Group of Patients With Myeloma Saw Better Outcomes
This article was originally published by Cancer Therapy Advisor Researchers have used deep whole-genome sequencing (WGS) to identify genomic markers...
Severe Renal Impairment Worsens Outcomes in Multiple Myeloma
This was originally published by AJMC Severe renal impairment (RI) is associated with decreased rates of survival among patients with multiple...
Inpatient Mortality With Renal Impairment in Patients With Multiple Myeloma
This article was originally published by Cancer Therapy Advisor Receipt of dialysis may be a risk factor for inpatient mortality in patients with...
Case Report Describes Late-onset MG in Man Treated for Multiple Myeloma
This post was originally published by Myasthenia Gravis News A 60-year-old man being treated for multiple myeloma was found to...
Cho Provides Background on the Multiple Myeloma Research Foundation’s CureCloud Study
This story was originally published by Targeted Oncology Hearn Jay Cho, MD, PhD, chief medical officer, Multiple Myeloma Research Foundation (MMRF),...
Gut Microbiome Could Play Key Role in Multiple Myeloma
This was originally published by AJMC The bone marrow (BM) microenvironment is believed to play a key role in the evolution of monoclonal gammopathy...